跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 61,124 条关于
“Janus kinase 1”
全部
61,124
临床试验
36,241
药物
7,604
机构
1,395
资讯
15,884
去年
Priovant Eyes Broad Autoimmune Applications for Brepocitinib After Promising Phase II Results
去年
CDSCO Expert Committee Accepts Pfizer's Phase III Data for Abrocitinib in Atopic Dermatitis
去年
FDA Grants Fast Track Designation to NS-229 JAK1 Inhibitor for Rare Autoimmune Disease EGPA
去年
Golidocitinib Plus PD-1 Antibodies Shows Promise in NSCLC Patients After Anti-PD-1 Therapy Failure
去年
Urticaria Clinical Trial Pipeline Heats Up with Novel Therapies in Development
去年
Biohaven Initiates Pivotal Phase II/III Trial of Brain-Penetrant TYK2/JAK1 Inhibitor BHV-8000 for Early Parkinson's Disease
去年
FDA Grants Orphan Drug Designation to NS-229 for Rare Vasculitis Condition
2个月前
Sareum Completes Dosing in Phase 2-Enabling Toxicology Programme for TYK2/JAK1 Inhibitor SDC-1801
去年
FDA Approves Aqilion's IND Application for AQ280 in Eosinophilic Esophagitis Treatment
11个月前
AbbVie's Rinvoq Becomes First Oral JAK Inhibitor Approved for Giant Cell Arteritis as Novartis' Cosentyx Fails Phase III Trial
第 1 页,共 1589 页
上一页
下一页